• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years.

    "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new territories, and establishing customer relationships. His experience and level of commitment bring an added degree of sophistication to our selling process. I have full confidence that he will continue to build an incredible sales team that compels surgeons, distributors, and the market to leverage Spineology technology," added Snider.

    Emory Rooney is joining Spineology with nearly two decades of medical device experience. Prior to joining Spineology, Mr. Rooney spent nearly six years with Alphatec Spine (NASDAQ:ATEC), where he served as the Vice President of Sales, East. Under his leadership his territory grew by ten times, achieving over $100 million in annual sales during his tenure. Prior to his time at ATEC, Mr. Rooney had a successful ten-year career with Stryker (NASDAQ:SYK), beginning with various sales representative roles at Stryker Navigation and Stryker Spine, and advancing into numerous leadership roles as a Branch manager, Regional Sales Manager and Area Vice President. Mr. Rooney also proudly serves as a board member for the International Spine Foundation, a non-profit that serves underprivileged spine patients in need of care. Mr. Rooney received his bachelor's degree in political science from the University of Central Florida.

    "The opportunity to join this growing team of spine experts compelled me to the Spineology organization," said Rooney. "After learning more about the versatility of the Optimesh® technology, and the incredible hospital access garnered by the uniqueness of the implant, one that is supported by IDE level data, it was an easy decision to jump on board. I am thrilled to join an organization that I know is set up for exceptional growth."

    With Mr. Rooney's hire, Spineology furthers its continued organizational expansion across the United States, with a core focus on its OptiMesh portfolio of implants.

    About Spineology

    Spineology Inc. leads the way in ultra-minimally invasive spine surgery, revolutionizing how surgeons treat patients with spinal pathologies. Its proprietary technology, OptiMesh sets the company apart from traditional fusion procedures enabling surgeons to optimize outcomes, while minimizing tissue disruption and enhancing patient recovery. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240404165010/en/

    Get the next $ATEC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC
    $SYK

    CompanyDatePrice TargetRatingAnalyst
    Stryker Corporation
    $SYK
    2/20/2026Outperform
    William Blair
    Stryker Corporation
    $SYK
    1/27/2026$387.00Hold
    TD Cowen
    Stryker Corporation
    $SYK
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    Stryker Corporation
    $SYK
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Alphatec Holdings Inc.
    $ATEC
    10/28/2025$20.00Buy
    Stifel
    Alphatec Holdings Inc.
    $ATEC
    10/24/2025$19.00Overweight
    Analyst
    Stryker Corporation
    $SYK
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    Alphatec Holdings Inc.
    $ATEC
    6/16/2025$18.00Buy
    Lake Street
    More analyst ratings

    $ATEC
    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker launches SmartHospital Platform

    New platform connects devices, data and care teams across the patient journey to streamline operations and enhance outcomes for patients and staffPORTAGE, Mich., March 9, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, today announced its new SmartHospital Platform, a digital foundation designed to connect devices, data and care teams across the hospital into one intelligent, adaptive ecosystem. The launch comes ahead of the 2026 HIMSS Global Conference & Exhibition and marks a significant expansion of Stryker's digital offerings. The SmartHospi

    3/9/26 9:07:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results

    Full-year 2025 total revenue grew 25% to $764 million, enabling significant profit margin expansion Full-year 2026 total revenue expected to approximate $890 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2025, and business highlights. Fourth Quarter and Full-Year 2025 Financial Results Quarter Ended December 31, 2025 Year Ended December 31, 2025 Total revenue $213 million $764 million GAAP gross margin 70% 70% Non-GAAP gross margin 7

    2/24/26 4:05:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    SEC Filings

    View All

    Alphatec Holdings Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    3/3/26 4:14:34 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Alphatec Holdings Inc.

    10-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    2/24/26 4:58:06 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    2/24/26 4:19:55 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, PEOPLE & CULTURE Hunsaker Craig E sold $1,441,041 worth of shares (116,367 units at $12.38) and gifted 600 shares, decreasing direct ownership by 6% to 1,725,609 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    3/10/26 6:00:05 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick covered exercise/tax liability with 219,749 shares, decreasing direct ownership by 4% to 5,778,551 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    3/9/26 3:00:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Koning John Todd covered exercise/tax liability with 68,910 shares, decreasing direct ownership by 9% to 680,510 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    3/9/26 3:00:08 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Stryker

    William Blair initiated coverage of Stryker with a rating of Outperform

    2/20/26 8:25:36 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    TD Cowen resumed coverage on Stryker with a new price target

    TD Cowen resumed coverage of Stryker with a rating of Hold and set a new price target of $387.00

    1/27/26 8:50:06 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Raymond James with a new price target

    Raymond James upgraded Stryker from Mkt Perform to Outperform and set a new price target of $418.00

    1/6/26 8:28:26 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

    Evolving technologies and offerings reinforce commitment to shaping the future of orthopaedic care PORTAGE, Mich., March 3, 2026 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases its commitment to innovation across orthopaedic specialties with the introduction of the newest additions to the Triathlon® Total Knee System, the expanded Mako SmartRobotics™ portfolio and continued evolution of the power tool portfolio at the American Academy of Orthopaedic Surgeons' (AAOS) 2026 Annual Meeting in New Orleans. Triathlon Gold: Building on the legacy

    3/3/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    2/4/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports 2025 operating results and 2026 outlook

    Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

    1/29/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

    Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended December 31, 2025 Surgical Revenue $189.3M to $190.0M $686.3M to

    1/12/26 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care